Open-Label, Randomized, 6-Way Crossover, Single-Dose Study to Determine the Pharmacokinetics of Batefenterol (GSK961081) and Fluticasone Furoate When Administered Alone or in Combination

Claire Ambery; Kylie Riddell; Peter Daley-Yates

doi:10.1002/cpdd.274

Open-Label, Randomized, 6-Way Crossover, Single-Dose Study to Determine the Pharmacokinetics of Batefenterol (GSK961081) and Fluticasone Furoate When Administered Alone or in Combination

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.274 ◽

2016 ◽

Vol 5 (5) ◽

pp. 399-407 ◽

Cited By ~ 5

Author(s):

Claire Ambery ◽

Kylie Riddell ◽

Peter Daley-Yates

Keyword(s):

Single Dose ◽

Fluticasone Furoate ◽

Open Label ◽

Single Dose Study ◽

Dose Study

Download Full-text

The Pharmacokinetics (PK), Safety and Tolerability of Fexofenadine HCl 6 mg/mL Suspension in Children with Allergic Rhinitis (AR): a Multicenter, Open-label, Single-dose Study

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2006.11.688 ◽

2007 ◽

Vol 119 (1) ◽

pp. S143

Author(s):

R.E. Grubbe ◽

A.S. Nayak ◽

B. Kittner ◽

N. Segall

Keyword(s):

Allergic Rhinitis ◽

Single Dose ◽

Open Label ◽

Single Dose Study ◽

Dose Study ◽

Fexofenadine Hcl

Download Full-text

P200 - A phase I, age and gender stratified, open-label, parallel-group, single-dose study assessing pharmacokinetics (PK) of a single 4.8 g oral dose of MMX™ the mesalazine in healthy volunteers

Journal of Crohn s and Colitis ◽

10.1016/s1873-9946(09)60227-0 ◽

2009 ◽

Vol 3 (1) ◽

pp. S89

Author(s):

D. Pierce ◽

A. Robinson ◽

M. Kern ◽

K. Barrett ◽

R. Karlstadt ◽

...

Keyword(s):

Single Dose ◽

Oral Dose ◽

Phase I ◽

Healthy Volunteers ◽

Open Label ◽

Age And Gender ◽

Single Dose Study ◽

Parallel Group ◽

Dose Study ◽

And Gender

Download Full-text

Absorption, Distribution, and Excretion of the Investigational Agent Orteronel (TAK-700) in Healthy Male Subjects: A Phase 1, Open-Label, Single-Dose Study

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.234 ◽

2016 ◽

Vol 5 (3) ◽

pp. 180-187

Author(s):

Ajit Suri ◽

Sandeepraj Pusalkar ◽

Yuexian Li ◽

Shimoga Prakash

Keyword(s):

Single Dose ◽

Phase 1 ◽

Healthy Male ◽

Open Label ◽

Single Dose Study ◽

Investigational Agent ◽

Dose Study ◽

Male Subjects

Download Full-text

An open label, single dose study to evaluate the safety, efficacy, and effects on CD25 expression of ciclosporin in patients with active rheumatoid arthritis despite treatment with methotrexate and infliximab

Annals of the Rheumatic Diseases ◽

10.1136/ard.2005.036152 ◽

2006 ◽

Vol 65 (4) ◽

pp. 538-541 ◽

Cited By ~ 7

Author(s):

P I Sidiropoulos

Keyword(s):

Rheumatoid Arthritis ◽

Single Dose ◽

Active Rheumatoid Arthritis ◽

Open Label ◽

Single Dose Study ◽

Cd25 Expression ◽

Dose Study

Download Full-text

Pharmacokinetics and Safety of DS-8500a, an Antidiabetic Drug, in Japanese Subjects with Hepatic or Renal Impairment: A Single-Center, Open-Label, Single-Dose Study

Advances in Therapy ◽

10.1007/s12325-018-0739-4 ◽

2018 ◽

Vol 35 (8) ◽

pp. 1239-1250 ◽

Cited By ~ 1

Author(s):

Manabu Kato ◽

Hitoshi Ishizuka ◽

Takashi Taguchi ◽

Kazuhito Shiosakai ◽

Emi Kamiyama ◽

...

Keyword(s):

Single Dose ◽

Renal Impairment ◽

Single Center ◽

Antidiabetic Drug ◽

Open Label ◽

Single Dose Study ◽

Dose Study ◽

Japanese Subjects

Download Full-text

2.45 A Phase 4, Open-Label, Multicenter, Single-Dose Study of the Pharmacokinetics of a Novel Amphetamine Extended-Release Oral Disintegrating Tablet Formulation (Adzenys XR-ODT™) in Preschool-Aged Children

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2018.09.133 ◽

2018 ◽

Vol 57 (10) ◽

pp. S173-S174

Author(s):

Robert A. Riesenberg ◽

Andrea Marraffino ◽

Dorothy Engelking ◽

Thomas Laage ◽

Andrew Volosov ◽

...

Keyword(s):

Single Dose ◽

Extended Release ◽

Tablet Formulation ◽

Open Label ◽

Single Dose Study ◽

Dose Study ◽

Oral Disintegrating Tablet ◽

Preschool Aged Children

Download Full-text

Influence of Renal Impairment on the Pharmacokinetics of Afatinib: An Open-Label, Single-Dose Study

European Journal of Drug Metabolism and Pharmacokinetics ◽

10.1007/s13318-016-0359-9 ◽

2016 ◽

Vol 42 (3) ◽

pp. 461-469 ◽

Cited By ~ 10

Author(s):

Sabrina Wiebe ◽

David Schnell ◽

Raimund Külzer ◽

Dietmar Gansser ◽

Anne Weber ◽

...

Keyword(s):

Single Dose ◽

Renal Impairment ◽

Open Label ◽

Single Dose Study ◽

Dose Study

Download Full-text

Correction to: An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysis

Pediatric Nephrology ◽

10.1007/s00467-018-4154-5 ◽

2018 ◽

Vol 34 (4) ◽

pp. 739-740

Author(s):

Winnie Y. Sohn ◽

Anthony A. Portale ◽

Isidro B. Salusky ◽

Hao Zhang ◽

Lucy L. Yan ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Single Dose ◽

Kidney Disease ◽

Pharmacokinetics And Pharmacodynamics ◽

Open Label ◽

Single Dose Study ◽

Dose Study

Download Full-text

Pharmacokinetics and Bioequivalence of 2 Tablet Formulations of Olanzapine in Healthy Chinese Volunteers: a Randomized, Open-Label, Single-Dose Study

Arzneimittelforschung ◽

10.1055/s-0032-1323659 ◽

2012 ◽

Vol 62 (11) ◽

pp. 508-512 ◽

Cited By ~ 4

Author(s):

Q. Chen ◽

M.-q. Zhang ◽

Y. Liu ◽

Y.-m. Liu ◽

S.-j. Li ◽

...

Keyword(s):

Single Dose ◽

Open Label ◽

Single Dose Study ◽

Dose Study ◽

Tablet Formulations ◽

Healthy Chinese

Download Full-text

Prophylactic use of anti-emetic medications reduced nausea and vomiting associated with exenatide treatment: a retrospective analysis of an open-label, parallel-group, single-dose study in healthy subjects

Diabetic Medicine ◽

10.1111/j.1464-5491.2010.03085.x ◽

2010 ◽

Vol 27 (10) ◽

pp. 1168-1173 ◽

Cited By ~ 14

Author(s):

C. Ellero ◽

J. Han ◽

S. Bhavsar ◽

B. B. Cirincione ◽

M. B. DeYoung ◽

...

Keyword(s):

Single Dose ◽

Retrospective Analysis ◽

Healthy Subjects ◽

Nausea And Vomiting ◽

Open Label ◽

Single Dose Study ◽

Parallel Group ◽

Dose Study ◽

Prophylactic Use

Download Full-text